436088-45-8Relevant articles and documents
Synthesis and biological evaluation of novel rhodanine-based structures with antiviral activity towards HHV-6 virus
Gentili, Valentina,Turrin, Giulia,Marchetti, Paolo,Rizzo, Sabrina,Schiuma, Giovanna,Beltrami, Silvia,Cristofori, Virginia,Illuminati, Davide,Compagnin, Greta,Trapella, Claudio,Rizzo, Roberta,Bortolotti, Daria,Fantinati, Anna
, (2021/12/02)
An increased awareness of diseases associated with Human herpesvirus 6 (HHV-6) infection or reactivation has resulted in a growing interest in the evaluation of the best treatment options available for the clinical management of HHV-6 disease. However, no
Novel broad spectrum virucidal molecules against enveloped viruses
Cagno, Valeria,Tintori, Cristina,Civra, Andrea,Cavalli, Roberta,Tiberi, Marika,Botta, Lorenzo,Brai, Annalaura,Poli, Giulio,Tapparel, Caroline,Lembo, David,Botta, Maurizio
, (2018/12/14)
Viral infections are an important cause of death worldwide. Unfortunately, there is still a lack of antiviral drugs or vaccines for a large number of viruses, and this represents a remarkable challenge particularly for emerging and re-emerging viruses. For this reason, the identification of broad spectrum antiviral compounds provides a valuable opportunity for developing efficient antiviral therapies. Here we report on a class of rhodanine and thiobarbituric derivatives displaying a broad spectrum antiviral activity against seven different enveloped viruses including an HSV-2 acyclovir resistant strain with favorable selectivity indexes. Due to their selective action on enveloped viruses and to their lipid oxidation ability, we hypothesize a mechanism on the viral envelope that affects the fluidity of the lipid bilayer, thus compromising the efficiency of virus-cell fusion and preventing viral entry.
2-Aminothiazolones as anti-hiv agents that act as gp120-cd4 inhibitors
Tiberi, Marika,Tintori, Cristina,Ceresola, Elisa Rita,Fazi, Roberta,Zamperini, Claudio,Calandro, Pierpaolo,Franchi, Luigi,Selvaraj, Manikandan,Botta, Lorenzo,Sampaolo, Michela,Saita, Diego,Ferrarese, Roberto,Clementi, Massimo,Canducci, Filippo,Botta, Maurizio
supporting information, p. 3043 - 3052 (2014/06/09)
We report here the synthesis of 2-Aminothiazolones along with their biological properties as novel anti-HIV agents. Such compounds have proven to act through the inhibition of the gp120-CD4 protein-protein interaction that occurs at the very early stage of the HIV-1 entry process. No cytotoxicity was found for these compounds, and broad antiviral activities against laboratory strains and pseudotyped viruses were documented. Docking simulations have also been applied to predict the mechanism, at the molecular level, by which the inhibitors were able to interact within the Phe43 cavity of HIV-1 gp120. Furthermore, a preliminary absorption, distribution, metabolism, and excretion (ADME) evaluation was performed. Overall, this study led the basis for the development of more potent HIV entry inhibitors.
